Alzheimer's drug hailed as a 'major' development
The first of a new class of treatments for Alzheimer's disease has been shown to be more than twice as effective as existing drugs in slowing progression of the condition, scientists said yesterday.
The drug, Rember, is the latest of a group of new treatments for the degenerative disease announced in the past two weeks but one with the greatest potential, experts said.
Rember is the first drug to act on the nerve tangles discovered by Alois Alzheimer a century ago which are thought to be the cause of the disease. The early (Phase 2) trial of 321 patients showed it slowed progression by 81 per cent compared with placebos.
The Alzheimer's Society described Rember as "a major new development" and said the results were "potentially exciting" but warned larger trials were needed. The drug was developed by scientists at the University of Aberdeen working with the Singapore-based company TauRx Therapeutics – a spin off from the university.
Professor Claude Wishcik, chairman of TauRx, who presented the findings at the International Conference on Alzheimer's Disease in Chicago yesterday, said: "This is an unprecedented result in the treatment of Alzheimer's Disease. We have demonstrated for the first time that it may be possible to arrest progression by targeting the tangles."
In a separate development, scientists from Imperial College London and the University of Uppsala, Sweden, reported that a new drug, PBT2, slows the build-up of protein leading to plaques. Results of the early trial, published in The Lancet Neurology and presented to the conference, show patients who took the drug over 12 weeks had significantly improved cognitive performance.
Much-loved cartoon character returns - without Sir David Jason
Liam Neeson's Downton dreams
Matt Smith is set to join cast of the Jane Austen classic - with a twist
Actress to appear in second series of the hugely popular crime drama
Olympic diver has made his modelling debut for Adidas
Life & Style blogs
Ebola outbreak: Survivor William Pooley is flown to US to give doctor with virus emergency blood transfusion
Jennifer Lawrence nude pictures leaked: Reddit removes 'The Fappening' board dedicated to sharing naked pictures of celebrities
Tezenis removes 'crime scene' pants from Oxford Street store after backlash over 'rape' connotations
A bottle of wine a day is not bad for you and abstaining is worse than drinking, scientist claims
iOS 8 review: not an overhaul, but the iPhone is gradually growing up
- 1 Thailand beach murders: Thai PM suggests 'attractive' female tourists cannot expect to be safe wearing bikinis
- 2 Scottish independence: Learn from Quebec's mistakes and beware of promises. Vote Yes.
- 3 'Necrophilia-obsessed' girl among double murder accused in three-way sex case
- 4 A bottle of wine a day is not bad for you and abstaining is worse than drinking, scientist claims
- 5 Revealed after 75 years of secrecy: 'Fifi' the glamorous WW2 special agent who tested British spies' resolve
£30000 - £35000 Per Annum Excellent benefits: Clearwater People Solutions Ltd:...
£40000 - £50000 Per Annum + excellent benefits: Clearwater People Solutions Lt...
£1036224 - £1513056 per annum: Randstad Education Cambridge: Randstad Educatio...
£21552 - £31588 per annum: Randstad Education Cambridge: Are you a fully quali...